Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-08 | Amended | $36,184,531 | $15,494,051 | Equity Only | 06b | SEC link |
| 2023-08-17 | New | $20,690,480 | $20,690,480 | Equity Only | 06b | SEC link |
| 2020-10-02 | New | $870,000 | $870,000 | Equity Only | 06b | SEC link |
| 2019-04-22 | Amended | $15,000,000 | $12,631,078 | Equity Only | 06b | SEC link |
| 2018-01-24 | New | $2,368,922 | $2,368,922 | Equity Only | 06b | SEC link |
| 2016-04-14 | Amended | $2,158,479 | $447,683 | Equity Only | 06b | SEC link |
| 2016-01-13 | New | $1,710,796 | $1,710,796 | Equity Only | 06b | SEC link |
| 2012-07-12 | New | $570,746 | $570,746 | Equity Only | 06 | SEC link |
| Name | Role |
|---|---|
| A. Clarke Atwell | Director, Executive |
| Terence Golden | Director |
| William Golden | Director, Executive |
| Houman Hemmati | Director |
| Michael Kaufman | Director |
| Eric Keller | Director |
| Gretchen Kraemer | Executive |
| Robert Langer | Director |
| John Mc Arthur | Director |
| Craig Nemiroff | Director |
| Ronald Poropatich | Director |
| George Sing | Director, Executive |
| Donald Wagner | Director |
| Patrick Welch | Executive |
| Patric Welch | Director, Executive |